华恒生物 (688639.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

23.6x

EV/EBITDA

16.8x

Market Cap

CNY 4.02B

MomentumView details →

1D Return

−3.65%

YTD Return

—

RSI (14)

56.0

ValuationView details →

P/E (Fwd)

23.6x

EV/EBITDA

16.8x

Market Cap

CNY 4.02B

RSI (14)

56.0

MomentumView details →

1D Return

−3.65%

YTD Return

—

ProfitabilityView details →

Gross Margin

20.48%

Net Margin

4.19%

EBITDA Margin

11.90%

ROE (TTM)

4.59%

ROA (TTM)

2.05%

Asset Turnover

0.50x

GrowthView details →

Revenue YoY

+24.61%

EPS YoY

−23.94%

FCF YoY

−20.53%

Revenue CAGR 3Y

+26.35%

EPS CAGR 3Y

−36.19%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.24

EPS Surprise

−3.15%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.38

Avg Surprise (4Q)

−3.15%

Rev Surprise

−1.08%

Capital & dividendView details →

Debt/Equity

0.72x

Current Ratio

1.21x

Quick Ratio

0.77x

Div Yield

0.90%

Div Rate

CNY 0.16

Div Growth 1Y

−36.00%

Financials snapshotView financials →

Revenue (TTM)

2.95B

Net Income (TTM)

123.41M

Op. CF (TTM)

101.90M

Next earningsOct 22, 2026 →

Latest newsMore news →

Huaheng Biology's actual controller Guo Henghua was approved for arrest by the procuratorate on suspicion of illegally absorbing public deposits; the company received notice from her family on July 31, 2026.35d ago

Huafeng Biology terminated its H-share listing plan on the Hong Kong Stock Exchange after Guo Henghua's detention.64d ago

Similar companies

Viking Therapeutics, Inc.VKTX TransThera Sciences (Nanjing) Inc.02617.HK Iovance Biotherapeutics, Inc.IOVA Telix Pharmaceuticals LimitedTLX Veradermics, IncorporatedMANE Relay Therapeutics, Inc.RLAY Find similar companies →

Latest newsMore news →

Huaheng Biology's actual controller Guo Henghua was approved for arrest by the procuratorate on suspicion of illegally absorbing public deposits; the company received notice from her family on July 31, 2026.35d ago Huafeng Biology terminated its H-share listing plan on the Hong Kong Stock Exchange after Guo Henghua's detention.64d ago Guo Henghua resigned from all positions including chairman and general manager of Huafeng Biology following her criminal detention.64d ago